Xeris Biopharma Holdings Inc
Xeris Biopharma Holdings Inc (XERS) Straddle
XERS straddle scan found 10 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 60.0%.
Read more
Trading a XERS straddle lets you take a pure volatility position on Xeris Biopharma Holdings Inc without committing to a direction. Xeris Biopharma Holdings Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate XERS straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on XERS profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Xeris Biopharma Holdings Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the XERS straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect.
The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the XERS straddle is the cleanest expression of that view. Our scanner prices every XERS straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a XERS straddle into a catalyst or short a XERS straddle to harvest decay, the options straddle setups that matter are all in one place.
| Apr 16, 2027 | 12.50 | $4.60 | 206 | 35% | 60.0% | $17.10 | $7.90 | 0 |
| Apr 16, 2027 | 10.00 | $3.20 | 206 | 35% | 58.3% | $13.20 | $6.80 | 0 |
| Jan 15, 2027 | 10.00 | $2.78 | 115 | 35% | 53.1% | $12.78 | $7.23 | 0 |
| Oct 16, 2026 | 10.00 | $1.78 | 24 | 35% | 45.9% | $11.78 | $8.23 | 1 |
| Apr 16, 2027 | 7.50 | $3.03 | 206 | 35% | 45.4% | $10.53 | $4.48 | 69 |
| Oct 16, 2026 | 7.50 | $1.50 | 24 | 35% | 43.5% | $9.00 | $6.00 | 434 |
| Nov 20, 2026 | 7.50 | $2.03 | 59 | 35% | 41.4% | $9.53 | $5.48 | 142 |
| Jan 15, 2027 | 5.00 | $4.10 | 115 | 35% | 39.0% | $9.10 | $0.90 | 194 |
| Jan 15, 2027 | 7.50 | $2.80 | 115 | 35% | 38.0% | $10.30 | $4.70 | 344 |
| Nov 20, 2026 | 10.00 | $2.85 | 59 | 35% | 37.4% | $12.85 | $7.15 | 0 |
As of September 25, 2026
Find the right straddle before volatility moves
Track XERS straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→